Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
Recruiting · NCT03655015 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Lung Tumor Resection
What this trial is about
Create a living biobank of PDOs from Stage I-III lung cancer patients.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Read, consented to and signed the IRB-approved informed consent form prior to any study related procedure.
- Diagnosis of lung cancer or lung mass or lymphadenopathy that will either systemic treatment or tumor resection as part of standard of care
- Any clinical stage of lung cancer
- Adult patients ≥18 years of age
- Able and willing to complete a questionnaire on their environmental/occupational exposures and smoking/alcohol history
Exclusion criteria
- At the discretion of the treating physician, patient will not be able to fulfill the requirements of the study.
Where it is running
1 location listed across 1 US state.
- UT Health San Antonio, M.D. Anderson Cancer Center - San Antonio, Texas, United States